Deep learning‐based model for diagnosing Alzheimer's disease and tauopathies

Aims This study aimed to develop a deep learning‐based model for differentiating tauopathies, including Alzheimer's disease (AD), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and Pick's disease (PiD), based on tau‐immunostained digital slide images. Methods We trai...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuropathology and applied neurobiology Ročník 48; číslo 1; s. e12759 - n/a
Hlavní autoři: Koga, Shunsuke, Ikeda, Akihiro, Dickson, Dennis W.
Médium: Journal Article
Jazyk:angličtina
Vydáno: England Wiley Subscription Services, Inc 01.02.2022
John Wiley and Sons Inc
Témata:
ISSN:0305-1846, 1365-2990, 1365-2990
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Aims This study aimed to develop a deep learning‐based model for differentiating tauopathies, including Alzheimer's disease (AD), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and Pick's disease (PiD), based on tau‐immunostained digital slide images. Methods We trained the YOLOv3 object detection algorithm to detect five tau lesion types: neuronal inclusions, neuritic plaques, tufted astrocytes, astrocytic plaques and coiled bodies. We used 2522 digital slide images of CP13‐immunostained slides of the motor cortex from 10 cases each of AD, PSP and CBD for training. Data augmentation was performed to increase the size of the training dataset. We next constructed random forest classifiers using the quantitative burdens of each tau lesion from motor cortex, caudate nucleus and superior frontal gyrus, ascertained from the object detection model. We split 120 cases (32 AD, 36 PSP, 31 CBD and 21 PiD) into training (90 cases) and test (30 cases) sets to train random forest classifiers. Results The resultant random forest classifier achieved an average test score of 0.97, indicating that 29 out of 30 cases were correctly diagnosed. A validation study using hold‐out datasets of CP13‐ and AT8‐stained slides from 50 cases (10 AD, 17 PSP, 13 CBD and 10 PiD) showed >92% (without data augmentation) and >95% (with data augmentation) diagnostic accuracy in both CP13‐ and AT8‐stained slides. Conclusion Our diagnostic model trained with CP13 also works for AT8; therefore, our diagnostic tool can be potentially used by other investigators and may assist medical decision‐making in neuropathological diagnoses of tauopathies. We developed a deep learning‐based tool for diagnosing Alzheimer’s disease (AD), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and Pick’s disease (PiD), based on tau‐immunostained digital slide images. Combining an object detection model that could recognize and count five tau lesion types and a random forest classifier could successfully differentiate four tauopathies. A validation study using hold‐out datasets of CP13‐ and AT8‐stained slides from 50 cases showed >95% diagnostic accuracy in both CP13‐ and AT8‐stained slides.
Bibliografie:Funding information
Jaye F. and Betty F. Dyer Foundation; Rainwater Charitable Trust; CurePSP Foundation; National Institutes of Health, Grant/Award Numbers: UG3 NS104095, R01 AG062348, U54 NS100693; Mayo Clinic Foundation for Medical Research
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Correction added on 23 September 2021, after first online publication: Peer review history statement has been added.
Funding information Jaye F. and Betty F. Dyer Foundation; Rainwater Charitable Trust; CurePSP Foundation; National Institutes of Health, Grant/Award Numbers: UG3 NS104095, R01 AG062348, U54 NS100693; Mayo Clinic Foundation for Medical Research
ISSN:0305-1846
1365-2990
1365-2990
DOI:10.1111/nan.12759